Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • MolecularHealth Expands U.S. Sales Team with Three Strategic New Hires

    Jul 29, 2014, 00:00 AM by Michael Croft
    THE WOODLANDS, TX, UNITED STATES - Jul 29, 2014 - In response to the company’s recent growth, MolecularHealth announced today the hiring of three new members of its U
    Full story
  • Cloud Weakness Exploited to Launch DDoS Attacks

    Jul 28, 2014, 10:00 AM by Michael Croft
    Computerworld | Attackers can target Amazon EC2 instances by exploiting a vulnerability in distributed search engine software, Computerworld is reporting. Researchers have found new variants of a Trojan program for Linux that launches denial-of-service (DDoS) attacks running on EC2 instances.
    Full story
  • Testing an Accelerated Path for Biosimilars

    Jul 28, 2014, 09:00 AM by Michael Croft
    Bio-IT World News Brief | For the first time, the FDA has accepted an application for a generic version of a biologic drug under the new regulatory pathway established by the Biologics Price Competition and Innovation Act of 2010.
    Full story
  • Outlook for Hepatitis Patients Set to Improve with Development of Accessible Treatments

    Jul 28, 2014, 00:00 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Jul 28, 2014 - The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline  identifying  multiple treatments in development that may serve as potential alternatives to Gilead’s Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill
    Full story
  • Cypher Genomics Signs Deal with Illumina, Expands Executive Team

    Jul 25, 2014, 13:00 PM by Michael Croft
    Bio-IT World News Brief | Cypher Genomics yesterday announced a sales deal with Illumina and added a host of new players to executive board positions.
    Full story
  • Rho Named a Best Place to Work by Triangle Business Journal for the Third Year in a Row

    Jul 24, 2014, 00:00 AM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Jul 24, 2014 - For Immediate release Rho Named a Best Place to Work byTriangle Business Journal for the Third Year in a RowCRO recognized for its company culture and flexible environmentChapel Hill, N
    Full story
  • With $650 Million Gift, Psychiatric Disorders Once Again in Limelight at the Broad

    Jul 23, 2014, 11:00 AM by Michael Croft
    Bio-IT World | Ted Stanley, the philanthropist whose 2007 gift of $100 million formed the basis of the Stanley Center for Psychiatric Research at the Broad Institute, has pledged an additional $650 million to the center.
    Full story
  • Dotmatics announce speaker line-up for User Group Meeting 2014

    Jul 23, 2014, 00:00 AM by Michael Croft
    BISHOP'S STORTFORD, UK - Jul 23, 2014 - ~~Dotmatics, a leading provider of informatics solutions to the pharma, biotech, chemical, agrochemical and academic industries, has released the agenda for their annual User Group Meeting
    Full story
  • Miyachi Unitek Introduces DC29 Linear DC Micro Welder

    Jul 23, 2014, 00:00 AM by Michael Croft
    MONROVIA, CA - Jul 23, 2014 - Miyachi Unitek Corporation, a leading manufacturer of welding equipment and systems, introduces the new DC29 linear DC micro welder, which offers precision control for small resistance welding applications
    Full story
  • DataDirect Networks Joins Global Alliance for Genomics and Health

    Jul 22, 2014, 15:00 PM by Michael Croft
    Santa Clara, Calif.—July 22, 2014 - Powering Over One-Third of the World’s Top SequencingCompanies, DDN Will Contribute Expertise in Data Representation, Storage, Analysis and Security of Genomic Data
    Full story
  • Dotmatics Appoints Shikha O’Brien as Vice President of Strategic Sales and Marketing

    Jul 22, 2014, 00:00 AM by Michael Croft
    BISHOP'S STORTFORD, UK - Jul 22, 2014 - ~~Dotmatics, a leading provider of scientific informatics solutions and services, is pleased to announce the appointment of Dr
    Full story
  • Tute Genomics Biomarker Discovery Platform to Support Brigham Young University’s Alzheimer’s Disease Genetics Research

    Jul 22, 2014, 00:00 AM by Michael Croft
    PROVO, NY, UNITED STATES - Jul 22, 2014 - Tute Genomics Biomarker Discovery Platform to Support Brigham Young University's Alzheimer's Disease Genetics Research Provo, Utah (July 22, 2014)  -- Tute Genomics today announced that its genome annotation and discovery platform will support Brigham Young University's (BYU) efforts to advance Alzheimer's disease genetics research
    Full story
  • Miyachi America Announces Sigma Femtosecond Laser Tube Cutter

    Jul 22, 2014, 00:00 AM by Michael Croft
    MONROVIA, CA - Jul 22, 2014 - Miyachi America Corporation, a leading manufacturer of laser welding, laser marking and micro machining equipment and systems, announces its new Sigma Femtosecond Laser Tube cutting system
    Full story
  • Roche Planning to Stay Out of Acquisitions

    Jul 21, 2014, 12:00 PM by Michael Croft
    Reuters | Roche is staying out of the pharma merger and acquisition fray, the CEO said. "We're sticking to our previous strategy... [of] small acquisitions and partnerships."
    Full story
  • Berry Genomics, Illumina Seek Chinese Regulatory Approval for NIPT

    Jul 21, 2014, 12:00 PM by Michael Croft
    Bio-IT World News Brief | Berry Genomics has chosen Illumina next-generation sequencing (NGS) technology as the platform on which Berry hopes to secure Chinese Food and Drug Administration (CFDA) regulatory approval for clinical applications. The combined "system" is in late stage CFDA testing, the Chinese company says.
    Full story
  • Universal Language: The Pistoia Alliance Takes on Indescribable Biology

    Jul 18, 2014, 10:50 AM by Michael Croft
    Bio-IT World | The Pistoia Alliance received a Best Practices Award at this year's Bio-IT World Conference & Expo for its work on HELM, a project that establishes a standard notation for complex macromolecules that are too large to sketch out atomically, but too heterogeneous to express as chains of RNA or amino acids. The project will aid interoperability across the industry, as pharma companies increasingly rely on strange, hybrid biochemistry in creating new therapeutics.
    Full story
  • Could CRISPR Transform Wild Ecosystems?

    Jul 18, 2014, 10:25 AM by Michael Croft
    Bio-IT World | In a paper published yesterday in the open access journal eLife, George Church and colleagues discuss the potential for "gene drives" that alter the genomes of whole wild populations using CRISPR gene editing technology, and weigh the risks and public interests surrounding such initiatives.
    Full story
  • Cloud Pharmaceuticals Enters R&D Agreement with Myos Corporation to Develop Small Molecules Targeting Sarcopenia and Cachexia

    Jul 17, 2014, 00:00 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC, UNITED STATES - Jul 17, 2014 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, has entered an R&D agreement with MYOS Corporation (“MYOS” or the “Company”) (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance
    Full story
  • Illumina Acquires Regulatory Strategy Consulting Firm

    Jul 16, 2014, 12:00 PM by Michael Croft
    Bio-IT World News Brief | Illumina today announced its acquisition of Myraqa, a consulting firm specializing in the regulatory strategy surrounding in vitro diagnostics, particularly companion diagnostics.
    Full story
  • Novartis Signs On to License Google's Glucose-Monitoring Contact Lenses

    Jul 16, 2014, 09:00 AM by Michael Croft
    New York Times | Google and Novartis have announced a partnership for Novartis to license Google's smart contact lens that could measure a wearer's blood sugar levels.
    Full story
  • «
  • 391
  • 392
  • 393
  • 394
  • 395
  • 396
  • 397 (current)
  • 398
  • 399
  • 400
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy